Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020

Overview of attention for article published in JAMA Neurology, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 30 news outlets
blogs: 1 blog
twitter: 23 X users
facebook: 1 Facebook page

reddit: 1 Redditor
video: 1 YouTube creator
podcasts: 1 podcast

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 34 news stories from 30 outlets.

S2 Episode 4: Should Platform Therapies Remain First-Line in MS?

Medscape, 18 Sep 2025

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…

Shift in Disease-Modifying Therapy Prescriptions for MS Observed From 2001 to 2020

Neurology Advisor , 03 Aug 2023

Oral disease-modifying therapies predominated new initiations for treatment of multiple sclerosis (MS) in 2020.

Shift in Rx From 2001 to 2020 for Disease-Modifying Therapy for Multiple Sclerosis

MPR, 28 Jul 2023

Credit:. Oral disease-modifying therapies dominated new initiations by 2020 to 62.3%.

2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis

CrossRoads Today abc25, 27 Jul 2023

THURSDAY, July 27, 2023 (HealthDay News) -- Oral disease-modifying therapies (DMTs) predominated new initiations for treatment…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 30 additional news stories.